Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^® and Liflow^®, announces the appointment of Jérôme Thiebaud as the Group's Chief Business Officer.

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^® and Liflow^®, announces the regulatory submission of its Liflow^® 1.0 solution (registered trademark of the Myra project), an oncology platform dedicated to the analysis of diagnostic imaging and cancer follow-up.

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and developer of Myrian^®, and Guerbet (FR0000032526 GBT), world leader in medical imaging, are proud to announce that the Myrian^® 2.12 platform has obtained CE certification under MDR, integrating prostate AI developed by Guerbet, the Veolity^® LungCAD AI developed by MeVis Medical Solutions AG and the Icobrain™ AI developed by Icometrix. This market launch is a major step in the two companies' joint development plan and the realization of their growth ambitions.

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^®, announces its participation at the ECR from February 28 to March 3, in Vienna (Austria).

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian^®, is proud to announce that the company has obtained the new CE certification under MDR (European Union Medical Device Regulation 2017/745), authorizing the marketing of the latest version of its Myrian^® solution.

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions and developer of Myrian^® (the "Company"), today announced its 2023 consolidated IFRS revenue (uncertified) at Group level.

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, has joined forces with the Montpellier Cancer Institute (ICM) through a partnership aimed at validating and then deploying its new platform dedicated to oncology in real-life situations, with the objective of using it in clinical routine.

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions ("Intrasense" or the "Company") announces that the Guerbet Group (FR0000032526 - GBT) has acquired a 39% stake in its share capital through a reserved share capital increase for a total amount of 8.8 million euros at an issuance price of 0.44 euro per share, representing a premium of 34.15% over the last closing price of the shares of Intrasense (the "Capital Increase").

Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and developer of Myrian® (the "Group"), today announces its 2022 IFRS Group consolidated half-year financial results.

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions, and MV, a key global player in the development of healthcare management software, announced the signing of a new contract to deploy the innovative solutions of the Myrian platform in Brazil, Panama, Colombia and Argentina.